Chinese Severe Brain Injury Trial | Clinical Trial

Key information

Conditions

Severe Brain Injury Brain Diseases Brain Injuries Central Nervous System Diseases Craniocerebral Trauma Nervous System Diseases Trauma, Nervous System Wounds and Injuries

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

a clear cause of brain injury
disorders of consciousness, GCS≤12
within six months of onset

Exclusion criteria

not applicable

Treatment and study plan

Primary outcomes

Glasgow Outcome Scale

Time frame: 6 months after severe Brain Injury

The unabbreviated scale title is Glasgow Outcome Scale. GOS includes a score of 1-5, with the higher the score, the better the prognosis.

Secondary outcomes

Glasgow Outcome Scale

Time frame: 3 months and 12 months after severe Brain Injury

The unabbreviated scale title is Glasgow Outcome Scale. GOS includes a score of 1-5, with the higher the score, the better the prognosis.

Study contacts

Contact information is provided by the study sponsor or research team.

Zhang Yan, MD

CONTACT

[email protected]

13671376710

Sponsors and collaborators

Lead sponsor

Xuanwu Hospital, Beijing

Other

Registry information

Acronym: CSBIT

Important dates

Study start: 2024
Primary completion: 2026
Study completion: 2027
First posted: Dec 22, 2023
Registry last updated: Dec 22, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting